Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Other companies in Cabaletta Bio’s space includes: Galectin Therapeutics (NASDAQ:GALT), Monopar Therapeutics (NASDAQ:MNPR), Atossa Therapeutics (NASDAQ:ATOS), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).
Cabaletta Bio has a consensus price target of $24.00.
The stock price for Cabaletta Bio (NASDAQ: CABA) is $2.4 last updated December 20, 2024 at 7:33 PM EST.
There are no upcoming dividends for Cabaletta Bio.
Cabaletta Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Cabaletta Bio.
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.